Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07363421 · ClinicalTrials.gov registry record · NA

TMS-Induced LH Response in Healthy Women in Luteal Phase

A NA study of Healthy Women, sponsored by The City College of New York.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT07363421 is a NA study of Healthy Women that is actively recruiting participants, run by The City College of New York. The registered enrollment target is 10 participants, below the 62-participant average among 4 other Healthy Women trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07363421, a NA study of Healthy Women, is actively recruiting participants, sponsored by The City College of New York.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to establish whether non-invasive Transcranial Magnetic Stimulation (TMS), can affect modulation of hormones such: Luteinizing Hormone (LH) and Follicle-stimulating hormone (FSH). The hypothesis is that applying TMS to the Dorsolateral Prefrontal Cortex with specific pulse patterns, mimicking endogenous Gonodotropin-Releasing Hormone (GnRH) pulses that are known to stimulate LH secretion may modulate hormonal levels.

Conditions Studied

Interventions

  • DEVICE Transcranial Magnetic Stimulation Sham
  • DEVICE Transcranial Magnetic Stimulation Active

Study Locations (1)

New York

  • Site 1 - New York

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-02-24
Est. Completion 2026-06-01
Phase NA

Sponsor

The City College of New York

7 total trials

What the Registry Record Tells You About NCT07363421

The ClinicalTrials.gov registry entry for NCT07363421 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 4 other Healthy Women trials with a reported enrollment target (84% lower). The listed sponsor is The City College of New York, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Women appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Magnetic Stimulation Sham is the first listed.

NCT07363421 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07363421 about?

NCT07363421 is a clinical study titled "TMS-Induced LH Response in Healthy Women in Luteal Phase". The purpose of this research is to establish whether non-invasive Transcranial Magnetic Stimulation (TMS), can affect modulation of hormones such: Luteinizing Hormone (LH) and Follicle-stimulating hormone (FSH). The hypothesis is that applying TMS to the Dorsolateral Prefrontal Cortex with specific...

What is the current status of trial NCT07363421?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-02-24. Estimated completion is 2026-06-01.

What conditions does trial NCT07363421 study?

This clinical trial studies the following conditions: Healthy Women.

What interventions are being tested in trial NCT07363421?

The interventions under investigation include: Transcranial Magnetic Stimulation Sham (DEVICE), Transcranial Magnetic Stimulation Active (DEVICE).

Who is sponsoring clinical trial NCT07363421?

This trial is sponsored by The City College of New York, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07363421 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Women

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.